Pharmacokinetic evaluation of two pirfenidone formulations in patients with idiopathic pulmonary fibrosis and chronic hypersensitivity pneumonitis-Reference-Cited by-同舟云学术

Pharmacokinetic evaluation of two pirfenidone formulations in patients with idiopathic pulmonary fibrosis and chronic hypersensitivity pneumonitis

Published:2020-10 Issue:10 Volume:6 Page:e05279
ISSN:2405-8440
Container-title:Heliyon
language:en
Short-container-title:Heliyon

Author:

Barranco-Garduño Lina Marcela,Buendía-Roldan Ivette,Rodriguez Juan Jose^ORCID,González-Ramírez Rodrigo^ORCID,Cervantes-Nevárez Ariadna N.,Neri-Salvador Juan Carlos,Carrasco-Portugal Miriam del Carmen,Castañeda-Hernández Gilberto,Martinez-Espinosa Karen,Selman Moisés,Flores-Murrieta Francisco Javier

Funder

Secretaría de Investigación y Posgrado, Instituto Politécnico Nacional

Publisher

Elsevier BV

Subject

Multidisciplinary

Reference20 articles.

1. Idiopathic pulmonary fibrosis;King;Lancet,2011

2. Aging and pulmonary fibrosis;Selman;Rev. Investig. Clin.,2016

3. Idiopathic Pulmonary Fibrosis;NIH,2011

4. Incidence and prevalence of idiopathic pulmonary fibrosis in US adults 18–64 years old;Raghu;Eur. Respir. J.,2016

5. A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis;King;N. Engl. J. Med.,2014

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pirfenidone use in fibrotic diseases: What do we know so far?;Immunity, Inflammation and Disease;2024-07

2. Prolonged-release pirfenidone in patients with pulmonary fibrosis as a phenotype of post-acute sequelae of COVID-19 pneumonia. Safety and efficacy;Respiratory Medicine;2023-10

3. Multicenter Population Pharmacokinetics and Exposure–Efficacy Analysis of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis;Clinical Pharmacokinetics;2023-05-04

4. A 3D culture system for evaluating the combined effects of cisplatin and anti-fibrotic drugs on the growth and invasion of lung cancer cells co-cultured with fibroblasts;APL Bioengineering;2023-03-01

5. Antifibrotic Effects of Caffeine, Curcumin and Pirfenidone in Primary Human Keratocytes;International Journal of Molecular Sciences;2023-01-11